Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer Therapy
U.S. FDA clears Axxent Electronic Brachytherapy System for treatment of breast cancer
February 2nd, 2006
Xoft, Inc., has received clearance from the U.S. Food & Drug Administration (FDA) for the Axxent Electronic Brachytherapy System for the treatment of breast cancer. Electronic brachytherapy is a proprietary technology platform designed to deliver localized, nonradioactive, isotope-free radiation treatment in a minimally shielded clinical setting under the supervision of a radiation oncologist. "We look forward to being able to offer this exciting new way to deliver nonradioactive radiation therapy for the treatment of breast cancer," said Vivek Mehta, MD, director for the Center of Advanced Targeted Radiation Therapy at the Swedish Cancer Institute...
Source: Women's Health Weekly (2006-02-02)
|
